IFPMA 2014 interview series ‘8th Asia Regulatory Conference’
Title: JPMA Welcome Message to the 8th Asia Regulatory Conference (ARC)
This short interview video is a prerecorded welcome message to the 8th Asia Regulatory Conference (ARC) posted online. Dr Inagaki talks about what the 2015 ARC conference in Chinese Taipei is all about. He also mentions the role played by the Asia Partnership Conference of Pharmaceutical Associations (APAC), a platform led by JPMA, in regulatory convergence. Dr Inagaki also explains why key players in the regulatory field in the region should not miss out on this event.
Dr Inagaki is the Staff Senior Executive Director, Global Planning and Administration, Astellas Pharma, and the chairperson of the Drug Evaluation Committee in the Japan Pharmaceutical Manufacturers Association (JPMA).
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.Learn more
Media ContactElliot Dunster email@example.com